Status:
UNKNOWN
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
South Australian Health and Medical Research Institute
Flinders University
Conditions:
Hepatitis C
Hepatitis
Eligibility:
All Genders
18+ years
Brief Summary
A community-based "test and treat" intervention integrating point-of-care HCV RNA testing, non-invasive liver disease assessment and linkage to care will lead to a reduction in HCV prevalence among pe...
Detailed Description
SCALE-C is an interventional cohort study recruiting people with or at risk of HCV infection from Aboriginal health services in Australia. Participants will be screened for HCV infection using point-o...
Eligibility Criteria
Inclusion
- 18 years of age or older;
- voluntarily signed the informed consent form.
Exclusion
- Pregnant women.
Key Trial Info
Start Date :
May 28 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03776760
Start Date
May 28 2019
End Date
August 1 2022
Last Update
April 14 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Jullums Lismore Aboriginal Medical Service
Lismore, New South Wales, Australia, 2480
2
Walhallow Aboriginal Corporation
Quirindi, New South Wales, Australia, 2343
3
Pangula Mannamurna Aboriginal Corporation
Mount Gambier, South Australia, Australia, 5290
4
Port Lincoln Aboriginal Health Service
Port Lincoln, South Australia, Australia, 5606